New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Researchers uncover molecular details of muscle contraction

Researchers uncover molecular details of muscle contraction

by Mario Aguilera,University of California - San DiegoIn a serendipitous discovery, UC San Diego researchers using cryo-EM technology captured the first visualizations of the 3D structure of the
Orthopedics & Sports medicine August 26,2024
Researchers uncover molecular details of muscle contraction

Researchers uncover molecular details of muscle contraction

by Mario Aguilera,University of California - San DiegoIn a serendipitous discovery, UC San Diego researchers using cryo-EM technology captured the first visualizations of the 3D structure of the
Orthopedics & Sports medicine August 26,2024
Controlling thickness in fruit fly hearts reveals new pathway for heart disease

Controlling thickness in fruit fly hearts reveals new pathway for heart disease

bySanford-Burnham PrebysThis graphical abstract uses images from the study's experiments to highlight major findings regarding the role of a protein called CREB-regulated transcription co-ac
Cardiovascular Diseases August 26,2024
Controlling thickness in fruit fly hearts reveals new pathway for heart disease

Controlling thickness in fruit fly hearts reveals new pathway for heart disease

bySanford-Burnham PrebysThis graphical abstract uses images from the study's experiments to highlight major findings regarding the role of a protein called CREB-regulated transcription co-ac
Cardiovascular Diseases August 26,2024
Can targeted therapies be applied to patients with Alzheimer's?

Can targeted therapies be applied to patients with Alzheimer's?

by Joe Lafata,University of UtahTara Mastren, center, is leading research into developing targeted alpha-particle therapies for patients with Alzheimer's. The University of Utah professor of
Neurology August 26,2024
Can targeted therapies be applied to patients with Alzheimer's?

Can targeted therapies be applied to patients with Alzheimer's?

by Joe Lafata,University of UtahTara Mastren, center, is leading research into developing targeted alpha-particle therapies for patients with Alzheimer's. The University of Utah professor of
Neurology August 26,2024
Serotonin-producing neurons regulate malignancy in ependymoma brain tumors

Serotonin-producing neurons regulate malignancy in ependymoma brain tumors

byBaylor College of MedicineStimulation of serotonergic neurons suppresses EPN tumorigenesis. Credit:Nature(2024). DOI: 10.1038/s41586-024-07751-zA study published inNature&nbs
Neurology August 26,2024
Serotonin-producing neurons regulate malignancy in ependymoma brain tumors

Serotonin-producing neurons regulate malignancy in ependymoma brain tumors

byBaylor College of MedicineStimulation of serotonergic neurons suppresses EPN tumorigenesis. Credit:Nature(2024). DOI: 10.1038/s41586-024-07751-zA study published inNature&nbs
Neurology August 26,2024
Researchers discover source of deadly fungal infections in bone marrow transplant patients

Researchers discover source of deadly fungal infections in bone marrow transplant patients

byEmory UniversityDavid Weiss, a professor at Emory University's School of Medicine and director of the Emory Antibiotic Resistance Center. Credit: Emory UniversityEmory researcher David Wei
Oncology August 26,2024
Researchers discover source of deadly fungal infections in bone marrow transplant patients

Researchers discover source of deadly fungal infections in bone marrow transplant patients

byEmory UniversityDavid Weiss, a professor at Emory University's School of Medicine and director of the Emory Antibiotic Resistance Center. Credit: Emory UniversityEmory researcher David Wei
Oncology August 26,2024
Propofol shows promise in treating epilepsy by targeting HCN1 channels

Propofol shows promise in treating epilepsy by targeting HCN1 channels

byWeill Cornell Medical CollegeAberrant signaling between neurons can result in epileptic seizures, which are characterized by bursts of high activity and can be detected by an electroencephalog
Neurology August 26,2024
Propofol shows promise in treating epilepsy by targeting HCN1 channels

Propofol shows promise in treating epilepsy by targeting HCN1 channels

byWeill Cornell Medical CollegeAberrant signaling between neurons can result in epileptic seizures, which are characterized by bursts of high activity and can be detected by an electroencephalog
Neurology August 26,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com